Cover Image
市場調查報告書

先天性遺傳基因·染色體異常遺傳基因檢驗:開發平台分析

Inborn Gene or Chromosome Alterations - Pipeline Review, 2015

出版商 GlobalData 商品編碼 342293
出版日期 內容資訊 英文 168 Pages
訂單完成後即時交付
價格
Back to Top
先天性遺傳基因·染色體異常遺傳基因檢驗:開發平台分析 Inborn Gene or Chromosome Alterations - Pipeline Review, 2015
出版日期: 2015年10月01日 內容資訊: 英文 168 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的先天性遺傳基因·染色體異常遺傳基因檢驗的相關產品 (檢查裝置·試劑等) 之開發中產品資訊相關分析,提供您臨床實驗/產品開發的整體進展,及各階段·各領域·各地區的詳細趨勢,各企業·各產品的詳細資訊 (臨床實驗的進展階段,開始/結束時期,認證預測等),近來的產品開發的動向·產業趨勢等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 先天性遺傳基因·染色體異常 (變性) 轉動遺傳基因檢驗概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各核審時期 (估計)
  • 現在進行中的臨床實驗

第4章 先天性遺傳基因·染色體異常遺傳基因檢驗:正在開發的開發中產品 (各企業)

  • 先天性遺傳基因·染色體異常遺傳基因檢驗的開發企業:開發中產品 (各開發階段)
  • 先天性遺傳基因·染色體異常遺傳基因檢驗:各開發階段的開發中產品一覽

第5章 先天性遺傳基因·染色體異常遺傳基因檢驗的開發企業·產品概要

  • AC-Gen Reading Life S.L.
    • 開發中產品及現在進行中的臨床實驗概要
  • Admera Health, LLC
  • Agena Bioscience, Inc
  • Ariosa Diagnostics, Inc.
  • Atomic International
  • Baylor College of Medicine
  • BCML GmbH
  • BioCeps (Inactive)
  • CardioDx, Inc.
  • Celera Corporation
  • Celula, Inc.
  • Children's Hospital Boston
  • China Medical Technologies, Inc.
  • Da An Gene Co., Ltd.
  • Dana-Farber Cancer Institute, Inc.
  • Epinex Diagnostics Incorporated
  • Genentech, Inc.
  • German Cancer Research Center
  • GILUPI Nanomedizin
  • Hadassah Medical Center
  • Helicos BioSciences Corporation
  • Illumina, Inc.
  • IntegraGen SA
  • Interleukin Genetics, Inc.
  • JS Genetics Inc.
  • Laboratory Corporation of America Holdings
  • Laval University
  • LifeCodexx AG
  • Maastricht University Medical Center
  • Massachusetts Eye and Ear Infirmary
  • Medical Research Council
  • Micromedic Technologies Ltd
  • Multiplicom N.V.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • National University of Singapore
  • NewGene Ltd
  • NX PharmaGen Inc.
  • Paragon Medical, Inc.
  • Population Diagnostics Inc.
  • Qiagen N.V.
  • Quantamerix
  • Sapien Biosciences
  • Seegene, Inc.
  • Sequenom, Inc.
  • Stanford University
  • The Johns Hopkins University
  • The Sheba Medical Center
  • The University of Utah
  • TrovaGene, Inc.
  • University of Colorado
  • University of Washington
  • VitaPath Genetics, Inc.
  • Xiamen Zeesan Biotech Co.,Ltd
  • Yale University

第6章 先天性遺傳基因·染色體異常遺傳基因檢驗:近來的市場趨勢

第7章 附錄

圖表一覽

目錄
Product Code: GDME0076EPD

GlobalData's Medical Devices sector report, "Inborn Gene or Chromosome Alterations - Pipeline Review, 2015" provides an overview of genetic tests for Inborn Gene or Chromosome Alterations currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key genetic tests for Inborn Gene or Chromosome Alterations pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the genetic tests for Inborn Gene or Chromosome Alterations under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of genetic tests for Inborn Gene or Chromosome Alterations and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of genetic tests for Inborn Gene or Chromosome Alterations under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Inborn Gene or Chromosome Alterations Overview

3. Products under Development

  • 3.1. Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
  • 3.2. Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
  • 3.3. Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
  • 3.4. Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
  • 3.5. Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials

4. Inborn Gene or Chromosome Alterations - Pipeline Products under Development by Companies

  • 4.1. Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development
  • 4.2. Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development

5. Inborn Gene or Chromosome Alterations Companies and Product Overview

  • 5.1. AC-Gen Reading Life S.L. Company Overview
    • 5.1.1. AC-Gen Reading Life S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Admera Health, LLC Company Overview
    • 5.2.1. Admera Health, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Agena Bioscience, Inc Company Overview
    • 5.3.1. Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Ariosa Diagnostics, Inc. Company Overview
    • 5.4.1. Ariosa Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Atomic International Company Overview
    • 5.5.1. Atomic International Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Baylor College of Medicine Company Overview
    • 5.6.1. Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. BCML GmbH Company Overview
    • 5.7.1. BCML GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. BioCeps (Inactive) Company Overview
    • 5.8.1. BioCeps (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. CardioDx, Inc. Company Overview
    • 5.9.1. CardioDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Celera Corporation Company Overview
    • 5.10.1. Celera Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Celula, Inc. Company Overview
    • 5.11.1. Celula, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Children's Hospital Boston Company Overview
    • 5.12.1. Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. China Medical Technologies, Inc. Company Overview
    • 5.13.1. China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Da An Gene Co., Ltd. Company Overview
    • 5.14.1. Da An Gene Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Dana-Farber Cancer Institute, Inc. Company Overview
    • 5.15.1. Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Epinex Diagnostics Incorporated Company Overview
    • 5.16.1. Epinex Diagnostics Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Genentech, Inc. Company Overview
    • 5.17.1. Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. German Cancer Research Center Company Overview
    • 5.18.1. German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. GILUPI Nanomedizin Company Overview
    • 5.19.1. GILUPI Nanomedizin Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Hadassah Medical Center Company Overview
    • 5.20.1. Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Helicos BioSciences Corporation Company Overview
    • 5.21.1. Helicos BioSciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Illumina, Inc. Company Overview
    • 5.22.1. Illumina, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. IntegraGen SA Company Overview
    • 5.23.1. IntegraGen SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. Interleukin Genetics, Inc. Company Overview
    • 5.24.1. Interleukin Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. JS Genetics Inc. Company Overview
    • 5.25.1. JS Genetics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Laboratory Corporation of America Holdings Company Overview
    • 5.26.1. Laboratory Corporation of America Holdings Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Laval University Company Overview
    • 5.27.1. Laval University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. LifeCodexx AG Company Overview
    • 5.28.1. LifeCodexx AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29. Maastricht University Medical Center Company Overview
    • 5.29.1. Maastricht University Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30. Massachusetts Eye and Ear Infirmary Company Overview
    • 5.30.1. Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31. Medical Research Council Company Overview
    • 5.31.1. Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32. Micromedic Technologies Ltd Company Overview
    • 5.32.1. Micromedic Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33. Multiplicom N.V. Company Overview
    • 5.33.1. Multiplicom N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34. Myriad Genetics, Inc. Company Overview
    • 5.34.1. Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35. Natera, Inc. Company Overview
    • 5.35.1. Natera, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.36. National University of Singapore Company Overview
    • 5.36.1. National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
  • 5.37. NewGene Ltd Company Overview
    • 5.37.1. NewGene Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.38. NX PharmaGen Inc. Company Overview
    • 5.38.1. NX PharmaGen Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.39. Paragon Medical, Inc. Company Overview
    • 5.39.1. Paragon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.40. Population Diagnostics Inc. Company Overview
    • 5.40.1. Population Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.41. Qiagen N.V. Company Overview
    • 5.41.1. Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.42. Quantamerix Company Overview
    • 5.42.1. Quantamerix Pipeline Products & Ongoing Clinical Trials Overview
  • 5.43. Sapien Biosciences Company Overview
    • 5.43.1. Sapien Biosciences Pipeline Products & Ongoing Clinical Trials Overview
  • 5.44. Seegene, Inc. Company Overview
    • 5.44.1. Seegene, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.45. Sequenom, Inc. Company Overview
    • 5.45.1. Sequenom, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.46. Stanford University Company Overview
    • 5.46.1. Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.47. The Johns Hopkins University Company Overview
    • 5.47.1. The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.48. The Sheba Medical Center Company Overview
    • 5.48.1. The Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • 5.49. The University of Utah Company Overview
    • 5.49.1. The University of Utah Pipeline Products & Ongoing Clinical Trials Overview
  • 5.50. TrovaGene, Inc. Company Overview
    • 5.50.1. TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.51. University of Colorado Company Overview
    • 5.51.1. University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
  • 5.52. University of Washington Company Overview
    • 5.52.1. University of Washington Pipeline Products & Ongoing Clinical Trials Overview
  • 5.53. VitaPath Genetics, Inc. Company Overview
    • 5.53.1. VitaPath Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.54. Xiamen Zeesan Biotech Co.,Ltd Company Overview
    • 5.54.1. Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.55. Yale University Company Overview
    • 5.55.1. Yale University Pipeline Products & Ongoing Clinical Trials Overview

6. Inborn Gene or Chromosome Alterations- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
  • Table 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
  • Table 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
  • Table 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
  • Table 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials
  • Table 6: Inborn Gene or Chromosome Alterations Companies - Pipeline Products by Stage of Development
  • Table 7: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
  • Table 8: AC-Gen Reading Life S.L. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Diagnostic Test - Hereditary Deafness - Product Status
  • Table 10: Diagnostic Test - Hereditary Deafness - Product Description
  • Table 11: Admera Health, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Diagnostic Test - Colorectal Cancer - Product Status
  • Table 13: Diagnostic Test - Colorectal Cancer - Product Description
  • Table 14: Agena Bioscience, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: IMPACT Dx Factor V Leiden and Factor II Genotyping Test - Product Status
  • Table 16: IMPACT Dx Factor V Leiden and Factor II Genotyping Test - Product Description
  • Table 17: Sensigene Trisomy 21 Test - Product Status
  • Table 18: Sensigene Trisomy 21 Test - Product Description
  • Table 19: Agena Bioscience, Inc - Ongoing Clinical Trials Overview
  • Table 20: Sensigene Trisomy 21 Test - Non-Invasive Screening For Fetal Aneuploidy: A New Maternal Plasma Marker
  • Table 21: Ariosa Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 22: Harmony Prenatal Test - Product Status
  • Table 23: Harmony Prenatal Test - Product Description
  • Table 24: Atomic International Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: Thrombophilia Genotyping Assay - Product Status
  • Table 26: Thrombophilia Genotyping Assay - Product Description
  • Table 27: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
  • Table 28: Diagnostic Assay - Rett Syndrome - Product Status
  • Table 29: Diagnostic Assay - Rett Syndrome - Product Description
  • Table 30: DNA Test - Autosomal Dominant Cerebellar Ataxia - Product Status
  • Table 31: DNA Test - Autosomal Dominant Cerebellar Ataxia - Product Description
  • Table 32: BCML GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Prenatal Diagnosis Biochip - Product Status
  • Table 34: Prenatal Diagnosis Biochip - Product Description
  • Table 35: BioCeps (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Prenatal Diagnostic Test - Product Status
  • Table 37: Prenatal Diagnostic Test - Product Description
  • Table 38: CardioDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: CardioDx Test - Heart Failure - Product Status
  • Table 40: CardioDx Test - Heart Failure - Product Description
  • Table 41: Genetic Susceptibility Test - Cardiac Arrhythmia - Product Status
  • Table 42: Genetic Susceptibility Test - Cardiac Arrhythmia - Product Description
  • Table 43: Celera Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Celera Thrombophilia Genotyping Assay - Product Status
  • Table 45: Celera Thrombophilia Genotyping Assay - Product Description
  • Table 46: Fragile - X Genotyping Assay - Product Status
  • Table 47: Fragile - X Genotyping Assay - Product Description
  • Table 48: Liver Fibrosis Genotyping Assay - Product Status
  • Table 49: Liver Fibrosis Genotyping Assay - Product Description
  • Table 50: Celula, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Non-Invasive Pre-Natal Test - Product Status
  • Table 52: Non-Invasive Pre-Natal Test - Product Description
  • Table 53: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Diagnostic Assay - Cystic Fibrosis - Product Status
  • Table 55: Diagnostic Assay - Cystic Fibrosis - Product Description
  • Table 56: Diagnostic Assay - Developmental Delay - Product Status
  • Table 57: Diagnostic Assay - Developmental Delay - Product Description
  • Table 58: China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: FISH Diagnostic Test - Soft Tissue Sarcoma - Product Status
  • Table 60: FISH Diagnostic Test - Soft Tissue Sarcoma - Product Description
  • Table 61: FISH Diagnostic Test - Urology - Product Status
  • Table 62: FISH Diagnostic Test - Urology - Product Description
  • Table 63: Da An Gene Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: Real Time PCR Kit - Alpha-Mediterranean Anaemia - Product Status
  • Table 65: Real Time PCR Kit - Alpha-Mediterranean Anaemia - Product Description
  • Table 66: Real Time PCR Kit - Beta-Mediterranean Anaemia - Product Status
  • Table 67: Real Time PCR Kit - Beta-Mediterranean Anaemia - Product Description
  • Table 68: Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 69: Diagnostic Assay - Fanconi Anemia - Product Status
  • Table 70: Diagnostic Assay - Fanconi Anemia - Product Description
  • Table 71: Diagnostic Assay - Pancreatic Cancer - Product Status
  • Table 72: Diagnostic Assay - Pancreatic Cancer - Product Description
  • Table 73: Epinex Diagnostics Incorporated Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Down Syndrome Screen Test - Product Status
  • Table 75: Down Syndrome Screen Test - Product Description
  • Table 76: Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: Arbaclofen Companion Diagnostic Assay - Product Status
  • Table 78: Arbaclofen Companion Diagnostic Assay - Product Description
  • Table 79: German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: CD24 Based Diagnostic Assay - Product Status
  • Table 81: CD24 Based Diagnostic Assay - Product Description
  • Table 82: Monoclonal Antibody - Neurofibromatosis - Product Status
  • Table 83: Monoclonal Antibody - Neurofibromatosis - Product Description
  • Table 84: GILUPI Nanomedizin Pipeline Products & Ongoing Clinical Trials Overview
  • Table 85: Diagnostic Test - Down's Syndrome - Product Status
  • Table 86: Diagnostic Test - Down's Syndrome - Product Description
  • Table 87: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 88: Gene Based Diagnostic Assay - Antipsychotic Induced Parkinsonism - Product Status
  • Table 89: Gene Based Diagnostic Assay - Antipsychotic Induced Parkinsonism - Product Description
  • Table 90: Helicos BioSciences Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 91: Prenatal Diagnostic Test - Product Status
  • Table 92: Prenatal Diagnostic Test - Product Description
  • Table 93: Illumina, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 94: Verifi Prenatal Test - Product Status
  • Table 95: Verifi Prenatal Test - Product Description
  • Table 96: IntegraGen SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 97: ARISk Test - V2.2 - Product Status
  • Table 98: ARISk Test - V2.2 - Product Description
  • Table 99: Interleukin Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 100: Inherent Health Osteoarthritis Test - Product Status
  • Table 101: Inherent Health Osteoarthritis Test - Product Description
  • Table 102: JS Genetics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 103: Dyslexia Predisposition Test - Product Status
  • Table 104: Dyslexia Predisposition Test - Product Description
  • Table 105: Laboratory Corporation of America Holdings Pipeline Products & Ongoing Clinical Trials Overview
  • Table 106: NGS-Based Universal Carrier Screening Test - Product Status
  • Table 107: NGS-Based Universal Carrier Screening Test - Product Description
  • Table 108: Laval University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 109: Trisomy 21 Blood Test - Product Status
  • Table 110: Trisomy 21 Blood Test - Product Description
  • Table 111: LifeCodexx AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 112: PCR-based NIPT assay - Product Status
  • Table 113: PCR-based NIPT assay - Product Description
  • Table 114: Maastricht University Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 115: MLPA Test - Product Status
  • Table 116: MLPA Test - Product Description
  • Table 117: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview
  • Table 118: GEDi Test - Inherited Eye Disorders - Product Status
  • Table 119: GEDi Test - Inherited Eye Disorders - Product Description
  • Table 120: GEDi Test - Strabismus - Product Status
  • Table 121: GEDi Test - Strabismus - Product Description
  • Table 122: Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview
  • Table 123: Genetic Test - Familial Hypercholesterolaemia - Product Status
  • Table 124: Genetic Test - Familial Hypercholesterolaemia - Product Description
  • Table 125: Micromedic Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 126: BONJ Risk Assessment Test - Product Status
  • Table 127: BONJ Risk Assessment Test - Product Description
  • Table 128: Multiplicom N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 129: Clarigo - Product Status
  • Table 130: Clarigo - Product Description
  • Table 131: Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 132: RAD51C Test - Product Status
  • Table 133: RAD51C Test - Product Description
  • Table 134: Natera, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 135: Anora Natera's Miscarriage Test - Product Status
  • Table 136: Anora Natera's Miscarriage Test - Product Description
  • Table 137: Horizon Multi-Disease Carrier Screening - Product Status
  • Table 138: Horizon Multi-Disease Carrier Screening - Product Description
  • Table 139: Spectrum PGD Test - Product Status
  • Table 140: Spectrum PGD Test - Product Description
  • Table 141: Spectrum PGS Test - Product Status
  • Table 142: Spectrum PGS Test - Product Description
  • Table 143: National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
  • Table 144: Rapid Screening Assay - Fragile X Syndrome - Product Status
  • Table 145: Rapid Screening Assay - Fragile X Syndrome - Product Description
  • Table 146: Rapid Screening Assay - Fragile X-Associated Tremor Ataxia Syndrome - Product Status
  • Table 147: Rapid Screening Assay - Fragile X-Associated Tremor Ataxia Syndrome - Product Description
  • Table 148: Rapid Screening Assay - Premature Ovarian Failure - Product Status
  • Table 149: Rapid Screening Assay - Premature Ovarian Failure - Product Description
  • Table 150: NewGene Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 151: Diagnostic Test - Colon Cancer - Product Status
  • Table 152: Diagnostic Test - Colon Cancer - Product Description
  • Table 153: Haemolytic Uremic Syndrome Test - Product Status
  • Table 154: Haemolytic Uremic Syndrome Test - Product Description
  • Table 155: Hereditary Non-Polyposis Colorectal Cancer Test - Product Status
  • Table 156: Hereditary Non-Polyposis Colorectal Cancer Test - Product Description
  • Table 157: Limb Girdle Muscular Dystrophy Test - Product Status
  • Table 158: Limb Girdle Muscular Dystrophy Test - Product Description
  • Table 159: NX PharmaGen Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 160: TAME-DX - Prenatal Diagnostic Assay - Product Status
  • Table 161: TAME-DX - Prenatal Diagnostic Assay - Product Description
  • Table 162: Paragon Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 163: Factor V Leiden For Thrombophilia Test - Product Status
  • Table 164: Factor V Leiden For Thrombophilia Test - Product Description
  • Table 165: Population Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 166: CLIA Waived Genetic Test - Alzheimer's Disease - Product Status
  • Table 167: CLIA Waived Genetic Test - Alzheimer's Disease - Product Description
  • Table 168: CLIA Waived Genetic Test - Autism - Product Status
  • Table 169: CLIA Waived Genetic Test - Autism - Product Description
  • Table 170: CLIA Waived Genetic Test - Parkinson's Disease - Product Status
  • Table 171: CLIA Waived Genetic Test - Parkinson's Disease - Product Description
  • Table 172: Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 173: Signature CF Expand - Product Status
  • Table 174: Signature CF Expand - Product Description
  • Table 175: Quantamerix Pipeline Products & Ongoing Clinical Trials Overview
  • Table 176: New Born Screening Diagnostic Device - Product Status
  • Table 177: New Born Screening Diagnostic Device - Product Description
  • Table 178: Sapien Biosciences Pipeline Products & Ongoing Clinical Trials Overview
  • Table 179: Genetic Testing Panel - Perinatal Disease - Product Status
  • Table 180: Genetic Testing Panel - Perinatal Disease - Product Description
  • Table 181: Seegene, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 182: Seeplex ApoE ACE Genotyping Assay - Product Status
  • Table 183: Seeplex ApoE ACE Genotyping Assay - Product Description
  • Table 184: Sequenom, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 185: MaterniT GENOME Test - Product Status
  • Table 186: MaterniT GENOME Test - Product Description
  • Table 187: Next Generation Noninvasive Prenatal Test (NIPT) - Product Status
  • Table 188: Next Generation Noninvasive Prenatal Test (NIPT) - Product Description
  • Table 189: Prenatal Diagnostic Test - Product Status
  • Table 190: Prenatal Diagnostic Test - Product Description
  • Table 191: SensiGene Age Related Macular Degeneration Assay - Product Status
  • Table 192: SensiGene Age Related Macular Degeneration Assay - Product Description
  • Table 193: VisibiliT Prenatal Test - Product Status
  • Table 194: VisibiliT Prenatal Test - Product Description
  • Table 195: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 196: Diagnostic Kit - Beta Thalassemia Syndrome - Product Status
  • Table 197: Diagnostic Kit - Beta Thalassemia Syndrome - Product Description
  • Table 198: The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 199: Prenatal Diagnostic Test - Product Status
  • Table 200: Prenatal Diagnostic Test - Product Description
  • Table 201: The Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 202: Non-Invasive Prenatal Diagnostic Assay - Product Status
  • Table 203: Non-Invasive Prenatal Diagnostic Assay - Product Description
  • Table 204: The University of Utah Pipeline Products & Ongoing Clinical Trials Overview
  • Table 205: Epigenetic Test - Disease Inheritance Risk In Offspring - Product Status
  • Table 206: Epigenetic Test - Disease Inheritance Risk In Offspring - Product Description
  • Table 207: TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 208: miRNA Test - Alzheimer's Disease - Product Status
  • Table 209: miRNA Test - Alzheimer's Disease - Product Description
  • Table 210: miRNA Test - Brain Stroke - Product Status
  • Table 211: miRNA Test - Brain Stroke - Product Description
  • Table 212: miRNA Test - Kidney Transplantation - Product Status
  • Table 213: miRNA Test - Kidney Transplantation - Product Description
  • Table 214: University of Colorado Pipeline Products & Ongoing Clinical Trials Overview
  • Table 215: CBS Gene Mutation Test - Product Status
  • Table 216: CBS Gene Mutation Test - Product Description
  • Table 217: University of Washington Pipeline Products & Ongoing Clinical Trials Overview
  • Table 218: Diagnostic Test - Ovarian Cancer - Product Status
  • Table 219: Diagnostic Test - Ovarian Cancer - Product Description
  • Table 220: VitaPath Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 221: Diagnostic Test - Spina Bifida - Product Status
  • Table 222: Diagnostic Test - Spina Bifida - Product Description
  • Table 223: Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 224: MeltPro HBB Diagnostic Kit - Product Status
  • Table 225: MeltPro HBB Diagnostic Kit - Product Description
  • Table 226: Yale University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 227: Diagnostic Assay - Down Syndrome - Product Status
  • Table 228: Diagnostic Assay - Down Syndrome - Product Description
  • Table 229: Glossary

List of Figures

  • Figure 1: Inborn Gene or Chromosome Alterations - Pipeline Products by Stage of Development
  • Figure 2: Inborn Gene or Chromosome Alterations - Pipeline Products by Territory
  • Figure 3: Inborn Gene or Chromosome Alterations - Pipeline Products by Regulatory Path
  • Figure 4: Inborn Gene or Chromosome Alterations - Pipeline Products by Estimated Approval Date
  • Figure 5: Inborn Gene or Chromosome Alterations - Ongoing Clinical Trials
Back to Top